The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Bank Clariden Leu, startups are often financed by U.S. Venture Partners (USVP), Nomura International, Cystic Fibrosis Foundation. The meaningful sponsors for the fund in investment in the same round are Warburg Pincus, U.S. Venture Partners (USVP), Phase4 Ventures. In the next rounds fund is usually obtained by QVT Financial, Horizon Technology Finance.
Among the most successful fund investment fields, there are Information Technology, Biotechnology. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Palatin Technologies, Altus Pharmaceuticals.
The top activity for fund was in 2004. Deals in the range of 10 - 50 millions dollars are the general things for fund. The increased amount of exits for fund were in 2006. The fund is generally included in less than 2 deals every year. The average startup value when the investment from Bank Clariden Leu is 50-100 millions dollars.
| Fund Name | Location |
| Black Swan Equity Partners LLP | - |
| C3E - Center of Excellence in Energy Efficiency | - |
| dunnhumby | England, London, United Kingdom |
| Elior Group | France, Ile-de-France, La Défense |
| EQx Fund | Boston, Massachusetts, United States |
| Ezdehar | - |
| Feng Xin | Beijing, China, Haidian |
| Fosun Group | China, Shanghai, Shanghai |
| Gaiax Japan | Chiyoda, Japan |
| Jundu Investment | Chengguan District, China, Lhasa |
| Livesense | Japan, Tokyo |
| Maryland Department of Business and Economic Development | Baltimore, Maryland, United States |
| NSE Investment | - |
| Piper Private Equity | England, London, United Kingdom |
| Rigel Asset Holdings | Austin, Texas, United States |
| Safe & Rich Venture Capital | China, Hangzhou, Zhejiang |
| Sitka Capital | Barcelona, Catalonia, Spain |
| TOUCH WOOD | China, Guangdong, Shenzhen |
| Ubiquiti Networks | - |
| Up Group | France, Gennevilliers, Ile-de-France |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Altus Pharmaceuticals | $51M | 26 May 2004 | Independence, Ohio, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Altus Pharmaceuticals | $51M | 26 May 2004 | Independence, Ohio, United States |
